| Satinder K Kathuria, | |
|
1740 W Taylor St, Chicago, IL 60612-7232 | |
| (866) 600-2273 | |
| Not Available |
| Full Name | Satinder K Kathuria |
|---|---|
| Gender | Female |
| Speciality | Pathology - Clinical Pathology/laboratory Medicine |
| Location | 1740 W Taylor St, Chicago, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316959984 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | 036044608 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Satinder K Kathuria, 809 S Marshfield Ave, 9th Floor (m/c 732), Chicago, IL 60612-4305 Ph: (312) 996-7699 | Satinder K Kathuria, 1740 W Taylor St, Chicago, IL 60612-7232 Ph: (866) 600-2273 |
News Archive
SNM is collaborating with the International Partnership for Critical Markers of Disease (CMOD) during CMOD's 7th Annual Biomarkers and Surrogate Endpoints Symposium, Bethesda North Marriott Hotel and Conference Center, Bethesda, Md., Oct. 19th, 2009.
Swiss researchers say they have had some encouraging results with an experimental anti-nicotine vaccine.
Endo Pharmaceuticals and Penwest Pharmaceuticals announced today that the companies have settled litigation with Impax Laboratories, Inc. regarding the production and sale of generic formulations of OPANA® ER (oxymorphone hydrochloride) Extended Release tablets.
Genetic differences that make some people susceptible to developing meningococcal meningitis and septicaemia, and others naturally immune, are revealed in a new study of over 6,000 people, published today in Nature Genetics.The research, led by Imperial College London and the Genome Institute of Singapore, is the largest ever genetic study of meningitis and septicaemia caused by meningococcal bacteria. It suggests that people who develop these diseases have innate differences in their natural defences that leave them unable to attack meningococcal bacteria successfully.
Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, today announces it has raised €4.8 million in a second closing of its Series A financing round from Forbion Capital Partners, a Dutch life-sciences venture capital firm, and Sunstone Capital, a Copenhagen based venture capital investor.
› Verified 2 days ago
Mark Wang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St, Feinberg Pavilion, Chicago, IL 60611 Phone: 312-503-8144 Fax: 312-502-8249 | |
Sandeep Gurbuxani, Pathology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Katrina Krogh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St Ste 7-132i, Chicago, IL 60611 Phone: 312-926-7913 Fax: 312-926-3127 | |
Dr. Carmencita Garcia Senseng, MD Pathology Medicare: Medicare Enrolled Practice Location: 1900 W Polk St, Chicago, IL 60612 Phone: 312-864-7561 | |
Suman Setty, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Jayme Brentan, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Dr. Megan Elizabeth Sullivan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-926-3211 |